treatment_phases
Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription
Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)
Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine
"Balance of supply for Initial treatment, Continuing treatment - subcutaneous form"
Continuing Treatment - balance of supply
Continuing or recommencement of treatment (within 12 months of a treatment break)
Continuing treatment
Continuing treatment - balance of supply
Continuing treatment in a patient weighing at least 30 kg
Continuing treatment in a patient weighing less than 30 kg
Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form
First Continuing treatment
First Continuing treatment - balance of supply
First continuing treatment
First continuing treatment - balance of supply
"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
Initial treatment
Initial treatment - Initial 1 (New patient)
Initial treatment - Initial 1 (new patient weighing at least 30 kg)
Initial treatment - Initial 1 (new patient weighing less than 30 kg)
Initial treatment - Initial 1 (new patient)
Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply
Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply
"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply"
Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years)
Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)
Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg)
Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)
Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)
Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg)
Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)
Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)
Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)
Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made
Subsequent continuing treatment
Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements